News
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
A federal judge says that recent layoffs at the U.S. Department of Health and Human Services were likely unlawful and must be ...
Synthetic products posing as kratom mislead and endanger consumers; AKA urges FDA to take decisive action against violative ...
A federal judge has ruled that recent mass layoffs at the US Department of Health and Human Services were likely unlawful and ...
WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...
1h
Grist on MSNHow to access food before, during, and after a disasterStore items in a cool, dry place away from direct sunlight. Place your food supply on high shelves to keep them far from any ...
As Chinese-developed drugs draw U.S. interest, a regulatory chill threatens to dampen new investment
Those questions, experts say, are based on the Trump administration’s hawkish approach to China generally, as well as on a ...
Americans are increasingly demanding that chemicals and toxic food dyes be removed from items they consume, clean with, wear, ...
The FDA has introduced Elsa, an internal AI tool to review safety data, identify labeling issues, and prioritize inspections, ...
The elimination of 3,500 full-time employees at the FDA risks undermining the very innovation and domestic capacity the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results